Search
Alaunos Therapeutics Inc
TCRTAdd to Watchlist
2.080USD
-0.080-3.70%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.95MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-3.70%
5 Days
0.00%
1 Month
-14.75%
6 Months
-36.59%
Year to Date
-35.60%
1 Year
-58.40%
Key Figures
2.185Open
2.200High
13.39KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.56%Turnover Ratio
2.160Prev. Close
2.070Low
19.51KTurnover
LossP/E Static
3.84P/B
0.00%Div Yield TTM
-205.30%ROA
6.20052wk High
0.93Volume Ratio
-4.68MNet Profit
2.38MShares
-1.9896EPS TTM
-1.06Beta
-350.30%ROE
1.67052wk Low
6.02%Amplitude
100.00%Gross Margin
4.95MMarket Cap
-2.04Reward/Risk
5.64%Risk Rate
TradingKey Stock Score of Alaunos Therapeutics Inc
Currency: USD Updated: 2026-07-02Key Insights
Alaunos Therapeutics Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 237 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Alaunos Therapeutics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Alaunos Therapeutics Inc Highlights
StrengthsRisks
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.00K.
Fairly Valued
The company’s latest PE is -1.05, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 172.58K shares, decreasing 10.33% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Alaunos Therapeutics Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Alaunos Therapeutics Inc Info
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
Ticker SymbolTCRT
CompanyAlaunos Therapeutics Inc
CEOWeis (Holger)
Websitehttps://alaunos.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Alaunos Therapeutics Inc (TCRT)?
The current price of Alaunos Therapeutics Inc (TCRT) is 2.08.
What is the symbol of Alaunos Therapeutics Inc?
The ticker symbol of Alaunos Therapeutics Inc is TCRT.
What is the 52-week high of Alaunos Therapeutics Inc?
The 52-week high of Alaunos Therapeutics Inc is 6.20.
What is the 52-week low of Alaunos Therapeutics Inc?
The 52-week low of Alaunos Therapeutics Inc is 1.67.
What is the market capitalization of Alaunos Therapeutics Inc?
The market capitalization of Alaunos Therapeutics Inc is 4.95M.
What is the Earnings Per Share (EPS TTM) of Alaunos Therapeutics Inc (TCRT)?
The Earnings Per Share (EPS TTM) of Alaunos Therapeutics Inc (TCRT) is -2.14.